27.10.2015 • NewsDede WillamsArkemasemiconductors

Arkema and Brewer Science in Semi-Conductor Deal

Arkema and Brewer Science have joined forces to produce high quality DSA (directed self assembly) materials for use in semiconductor manufacturing.

The future partners said the pooling of their manufacturing and support expertise will accelerate the introduction of DSA material technology for next-generation lithography applications. DSA, they explain, will be one of the key technologies that enable high-volume, cost-effective nanoscale manufacturing.

The collaboration will leverage Brewer Science’s more than 30-years of experience in advanced semiconductor materials and process solutions to add to the French chemical producer’s more than 20 years of experience in block copolymer (BCP) technology and manufacturing.

Together, the companies plan to bring process stability to DSA by providing BCP in volume to support an entire node life with a single batch while also offering a wide range of process flexibility through a full suite of DSA flow materials and Arkema’s BCP blending process.

Daniel Sullivan, director of Brewer Science’s semiconductor R&D, said the goal is to provide a turnkey DSA process so customers can obtain all the materials and process knowledge needed to implement DSA quickly and cost effectively.

Arkema’s scientific director, Ian Cayrefourcq, said the French company “is committed to delivering high quality DSA material to the semiconductor market.” He said the partnership with Brewer Science will accelerate the introduction of a commercial solution on the market and provide a unique support to our future customers built on the strength of both companies.”

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.